Horizon Technology Finance Corp experienced significant volatility over recent years, transitioning from a steep net loss of $17.2 million in 2023 toward a much narrower loss of $2.7 million in 2025, accompanied by a remarkable operating cash flow recovery to $56.6 million in 2025. The company’s focused debt investments across technology-driven niche sectors like biotechnology, medical devices, and sustainable energy underpin its specialized moat and risk management framework. Currently undergoing a pivotal merger with Monroe Capital Corporation involving stock issuance and cash consideration, Horizon faces key risks including transaction completion uncertainty and post-merger integration challenges. Going forward, monitoring portfolio credit quality, dividend sustainability, and the closure of merger conditions will be essential.